SEER Inquiry System - Report
Produced: 10/04/2025 12:50 PM
Question 20041054
Inquiry Details
References:
CS Manual, Part II. Vers 1.0, Jan. 1, 2004
Question:
Discussion:
Answer:
This answer was provided in the context of CSv1 coding guidelines. The response may not be used after your registry database has been converted to CSv2.
Yes. Code CS Extension-Clinical Extension to 15 [Tumor identified by needle biopsy, e.g., for elevated PSA (clinically inapparent)] for clinically inapparent prostate cancer with positive apex biopsy.